We developed a method for quantitatively determining theophylline in serum, using a heterogeneous immunoassay called flow-injection immunoanalysis. The reaction involves competition between serum theophylline and theophylline-labeled liposomes. Separation occurs on a solid-phase reactor column containing immobilized antibody to theophylline incorporated in a flow-injection system. Subsequent lysis of the bound liposomes provides sensitive detection oftheanalyte. 
ate in aqueous solution to form submicroscopic, spherical structures composed of a bilayer membrane enclosing an aqueous volume. They can be made immunogenic by incorporating a phospholipid that has an antigen or antibody associated with its head group. Each liposome can have tens of thousands of detectable water-soluble molecules trapped inside and thus is capable of having a significant advantage over a diagnostic reagent that is labeled with only one or several such detectable molecules. Liposomes have been used most often in homogeneous-phase assays requiring the lysis of immunospecific liposomes and also as reagents in solid-phase assays (1). We showed that liposomes containing fluorescent molecules can provide 100-fold greater sensitivity than an enzyme label in solid-phase enzyme-linked immunosorbent assay (2) .
We described previously the use of liposomes in solidphase immunoassays ( 10_16 mol/mm2 of silica particle surface.
The silica particles were packed into a 2 mm (i.d.) x 10cm glass column. The total amount of active antibody binding sites per column was -2 X 1012 mol. Nylon mesh frits (60 jim) were used to retain the particles in the column. The packed column was used and stored at room temperature. 
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Fig. 2. Immunoassayreactionsequence
Step 1: antibodies Immobilized in the reactor column. Step2: competitive reaction between iiposomes and theophliine on the immobilIzed-antibody column.
Step 3: lysls of the liposomes;where the analyticalsignal is detected.
Step 4: releaseofthe sample theophyllinefrom the antibodyby massaction in the continuouslyflowing buffer solution Table 2 show a single serum-based calibration theophylline solution with an initial concentration of 2.5 mg/L measured on six different days. A calibration curve was generated as described above on day 1. The highest within-day SD in peak height was 6% and the average was 4%. The day-to-day variability of the peak heights was 9.3% over 44 days of measurements (days .
With a single calibration curve (generated on day 1) being used to calculate the concentration of the theophylline over 54 days, the highest within-day CV was 18% and the average was 15%. However, when fresh plasma (mixed with EDTA) was tested in the FLIA system, there was a slight downward trend in the peak height, but the CV for eight measurements over 2 h was 2.7%. Thus, prevention of sample Figure 5B is conditions, >99% of the theophylline-antitheophylline complexes are dissociated by mass action. However, the apparent affinity constant of the intact liposomes for the same immobilized antibody was 60 Lfnmol with a half-time of dissociation of 40 mm (5). Therefore, there is essentially no loss of bound liposomes from the column before lysis with surfactant. After rupture of the bound liposomes with surfactant, any remaining bound theophylline-lipid monomer dissociates with the same rapid rate as theophylline. Thus, regeneration of the column is complete in two steps after the competitive reaction; first, surfactant flows through the column, disrupting bound liposomes; second, buffer flows through the reactor column, maintaining an infinite dilution of antigen concentration at the surface. We achieve the following advantages by using antibodies with a fast dissociation rate and liposomes with a very slow dissociation rate: removal of potential optical interferents from the analytical signal before the fluorescence detection, high fluorescence yield from the liposomes, and quantitative disruption of the antigenantibody complexes and regeneration of column activity for the next injection without the use of harsh chaotropic reagents.
